Aardvark Therapeutics, Inc. (AARD): 9 insider purchases in the last two years.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Dec 12, 2025 | Lee Tien-Li Director, Officer, TenPercentOwner | 7,000 | $14.49 | $101.4K | no history |
| Dec 12, 2025 | Sun Nelson Officer | 3,000 | $14.40 | $43.2K | no history |
| Sep 16, 2025 | Lee Tien-Li Director, Officer, TenPercentOwner | 10,000 | $9.66 | $96.6K | no history |
| Sep 12, 2025 | Lee Tien-Li Director, Officer, TenPercentOwner | 20,000 | $8.03 | $160.6K | no history |
| Sep 10, 2025 | Sun Nelson Officer | 6,000 | $8.07 | $48.4K | no history |
| Feb 19, 2025 | Chen Bihua Other | 187,500 | $16.00 | $3.0M | no history |
| Feb 19, 2025 | Sun Nelson Officer | 10,000 | $16.00 | $160.0K | no history |
| Feb 19, 2025 | Lee Tien-Li Director, Officer, TenPercentOwner | 16,542 | $16.00 | $264.7K | no history |
| Feb 19, 2025 | Decheng Capital Global Life Sciences Fund IV, L.P. TenPercentOwner | 1,250,000 | $16.00 | $20.0M | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.